• Patients

    Learn more about LuCED, VisionGate’s non-invasive diagnostic test to aid physicians in the early detection of lung cancer.

    Learn more

  • Physicians

    LuCED is a non-invasive, cost-effective test to precede, supplement or follow low-dose CT scans.

    Learn more

  • Researchers

    VisionGate has ongoing research opportunities and continues to grow its team of collaborative partners from around the world.

    Learn more


17th World Conference on Lung Cancer: VisionGate Will Present Twice!

CEO Alan Nelson, PhD, and CMO Javier Zulueta, MD, to Present Two Pivotal Papers in Vienna, Austria on December 5, 2016


VisionGate to speak for the exclusive Piper Jaffray Conference

CEO Alan Nelson, PhD, to Present at the Lotte New York Palace Hotel on November 29, 2016


VisionGate Hires Renowned Chief Medical Officer Dr. Javier Zulueta

Dr. Zulueta led the longest ongoing lung cancer screening trial in Europe


Copyright 2016 - VisionGate, Inc.